Ludwig Institute for Cancer Research Ltd;CSL Limited
发明人:
Behren, Andreas,Cebon, Jonathan,Hudson, Christopher,Woods, Katherine,Hammet, Andrew,Verhagen, Anne,Maraskovsky, Eugene,Panousis, Con
申请号：
AU2014354587
公开号：
AU2014354587A1
申请日:
2014.11.28
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present disclosure provides a method for enhancing or inducing an immune response and/or for inducing lysis of cancer cells and/or for treating cancer in a subject, the method comprising administering to the subject a compound that neutralizes BTN2A1 and/or that binds to BTN2A1 on the cells and induces death of the cells.
